O
Olivier Elemento
Researcher at Cornell University
Publications - 596
Citations - 38936
Olivier Elemento is an academic researcher from Cornell University. The author has contributed to research in topics: Medicine & Biology. The author has an hindex of 82, co-authored 471 publications receiving 27739 citations. Previous affiliations of Olivier Elemento include Princeton University & Max Planck Society.
Papers
More filters
Journal ArticleDOI
Blood biomarkers reflect the effects of obesity and inflammation on the human breast transcriptome.
Byuri Angela Cho,Neil M. Iyengar,Xi Kathy Zhou,Monica Morrow,Dilip Giri,Akanksha Verma,Olivier Elemento,Michael Pollak,Andrew J. Dannenberg +8 more
TL;DR: In this paper, the authors carried out transcriptome profiling to define the molecular changes that occur in the breast related to excess body fat and white adipose tissue (WAT) inflammation.
Journal ArticleDOI
Cohesin Core Complex Gene Dosage Contributes to Germinal Center Derived Lymphoma Phenotypes and Outcomes
Martín A. Rivas,Ceyda Durmaz,Andreas Kloetgen,Cristopher R Chin,Zhengming Chen,Bhavneet Bhinder,Amnon Koren,Aaron D. Viny,Christopher D. Scharer,Jeremy M. Boss,Olivier Elemento,Christopher E. Mason,Ari Melnick +12 more
TL;DR: In this article, the authors explored potential mechanisms and clinical relevance of cohesin deficiency in germinal center (GC) derived lymphoma in mice and found that cohesins deficiency largely induces lymphomas through disruption of enhancer-promoter interactions of terminal differentiation and tumor suppressor genes.
Journal ArticleDOI
CHL1 expression differentiates Hürthle cell carcinoma from benign Hürthle cell nodules.
Wei Li,Shujun Xia,Anna Aronova,Irene M. Min,Akanksha Verma,Theresa Scognamiglio,Katherine D. Gray,Timothy M. Ullmann,Heng Liang,Maureen D. Moore,Olivier Elemento,Rasa Zarnegar,Thomas J. Fahey +12 more
TL;DR: The aim of this study was to determine whether differences in the expression of specific genes could differentiate HCC from benign Hürthle cell nodules by evaluating differential gene expression in Hürthy cell disease.
Journal ArticleDOI
Endothelial-leukemia interactions remodel drug responses uncovering T-ALL vulnerabilities.
Luca Vincenzo Cappelli,Danilo Fiore,Jude M. Phillip,Liron Yoffe,Filomena Di Giacomo,William Chiu,Yang Hu,Clarisse Kayembe,Michael Ginsberg,Lorena Consolino,José Gabriel Barcia Durán,Nahuel Zamponi,Ari Melnick,Francesco Boccalatte,Wayne Tam,Olivier Elemento,Sabina Chiaretti,Anna Guarini,Robin Foà,Leandro Cerchietti,Shahin Rafii,Giorgio Inghirami +21 more
TL;DR: It is found that ECs provide pro-tumorigenic signals and mitigate drug responses to individual T-ALL PDXs suggesting unique crosstalk interactions and/or intrinsic tumor features and can contribute to elucidating leukemia-microenvironment interactions and identify effective compounds and therapeutic vulnerabilities.
Journal ArticleDOI
BTG1 mutation yields supercompetitive B cells primed for malignant transformation
Coraline Mlynarczyk,Matt Teater,Juhee Pae,Christopher R. Chin,Lin Wang,Theinmozhi Arulraj,Darko Barišić,Antonin Papin,Kenneth B. Hoehn,Ekaterina D. Kots,Jonatan Ersching,Arnab Bandyopadhyay,Ersilia Barin,Hui Xian Poh,Chiara M. Evans,Amy Chadburn,Zhengming Chen,Hao Shen,Hannah M. Isles,Ben Pelzer,Ioanna Tsialta,Ashley S. Doane,Huimin Geng,Muhammad Hassan Rehman,Jonah Melnick,Wyatt Morgan,Diu T.T. Nguyen,Olivier Elemento,Michael G. Kharas,Samie R. Jaffrey,David Scott,George Khelashvili,Michael Meyer-Hermann,Gabriel D. Victora,Ari Melnick +34 more
TL;DR: Mlynarczyk et al. as mentioned in this paper found that mutations affecting BTG1 disrupt a critical immune gatekeeper mechanism that strictly limits B cell fitness during antibody affinity maturation, leading to aggressive invasive lymphomas.